Skip to search formSkip to main contentSkip to account menu

harmalol

Known as: 4,9-dihydro-1-methyl-3H-pyrido(3,4-b)indol-7-ol 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (1)

Harmaline
analogs & derivatives

Narrower (2)

harmalol dihydrochlorideharmalol hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Therapeutic Role of Harmalol Targeting Nucleic Acids: Biophysical Perspective and in vitro Cytotoxicity.
BACKGROUND Harmalol, a beta carboline alkaloid, shows remarkable importance in the contemporary biomedical research and drug… 
Highly Cited
1993
Highly Cited
1993
Photochemical reactions of harmalol. II. Electronic spectra
Electronic spectra (absorption, emission and excitation fluorescence spectra) of harmalol in organic solvents have been recorded… 
1992
1992
Study of the in vitro antimicrobial activity of harmine, harmaline and their derivatives.
1982
1982
Rat brain aryl acylamidase: further characterization of multiple forms.
1981
1981
The effect of harmaline and related beta-carbolines on the acetylcholine-stimulated contractions of guinea-pig ileum.
1975
1975
The action of some harmala alkaloids on transmission at a glutamate-mediated synapse
1974
1974
On non-specific inhibition of rat liver microsomal UDP glucuronyltransferase by some drugs.
1971
1971
Metabolism of harmaline in rats.
1968
1968
Glucuronidation of 3-O-methylnoradrenaline, harmalol and some related compounds.
1. The following compounds were glucuronidated in the presence of UDP-glucuronic acid and a microsomal preparation made from… 
1967
1967
Determination of UDPG and UDPGA in tissues.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)